Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation 英文参考文献.docVIP

  • 2
  • 0
  • 约5.32万字
  • 约 12页
  • 2017-05-12 发布于上海
  • 举报

Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation 英文参考文献.doc

Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation 英文参考文献

LaropiprantAttenuatesEP3andTPProstanoidReceptor- MediatedThrombusFormation SoniaPhilipose1,ViktoriaKonya1,MirjanaLazarevic1,LisaM.Pasterk1,GuntherMarsche1,SasaFrank2, BernhardA.Peskar1,AkosHeinemann1*,RufinaSchuligoi1 1InstituteofExperimentalandClinicalPharmacology,MedicalUniversityofGraz,Graz,Austria,2InstituteofMolecularBiologyandBiochemistry,MedicalUniversityof Graz,Graz,Austria Abstract The use of the lipid lowering agent niacin is hampered by a frequent flush response which is largely mediated by prostaglandin(PG)D2.Therefore,concomitantadministrationoftheD-typeprostanoid(DP)receptorant

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档